Home688062 • SHA
add
Mabwell Shanghai Bioscience Co Ltd
Previous close
¥23.88
Day range
¥22.38 - ¥24.65
Year range
¥19.90 - ¥37.00
Market cap
8.94B CNY
Avg Volume
4.75M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 25.57M | 167.73% |
Operating expense | 260.55M | -5.57% |
Net income | -249.11M | 4.10% |
Net profit margin | -974.30 | 64.18% |
Earnings per share | — | — |
EBITDA | -217.48M | 12.12% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.59B | -12.22% |
Total assets | 4.50B | 1.06% |
Total liabilities | 2.59B | 68.75% |
Total equity | 1.90B | — |
Shares outstanding | 399.60M | — |
Price to book | 4.98 | — |
Return on assets | -12.81% | — |
Return on capital | -14.02% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -249.11M | 4.10% |
Cash from operations | -206.60M | 14.31% |
Cash from investing | -61.28M | 16.77% |
Cash from financing | 130.48M | 269.74% |
Net change in cash | -138.56M | 49.79% |
Free cash flow | -369.56M | 17.24% |
About
Founded
May 12, 2017
Website
Employees
1,402